Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trudi McDevitt

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
European Journal of Human Genetics : EJHG|December 4, 2008
When good CF tests go badTrudi McDevitt, David Barton
Cancer Genetics|August 8, 2015
Protein-truncating variants in moderate-risk breast cancer susceptibility genes: a meta-analysis of high-risk case-control screening studiesFatima Aloraifi, Damian McCartan, Trudi McDevitt, et al.
Cancer Genetics|June 10, 2017
Recurrent large genomic rearrangements in BRCA1 and BRCA2 in an Irish case seriesTerri P McVeigh, Nuala Cody, Cliona Carroll, et al.
Human Mutation|June 20, 2003
Comparison of the CFTR mutation spectrum in three cohorts of patients of Celtic origin from Brittany (France) and IrelandVirginie Scotet, David E Barton, James B G Watson, et al.
Irish Journal of Medical Science|October 19, 2022
Uptake of BRCA1/BRCA2 predictive genetic testing in an Irish population is low: a missed opportunityDavid E O'Reilly, Lucy Dooley, Geoffrey A Watson, et al.
European Journal of Human Genetics : EJHG|August 2, 2024
Correction: EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancerTrudi McDevitt, Miranda Durkie, Norbert Arnold, et al.
European Journal of Human Genetics : EJHG|March 5, 2024
EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancerTrudi McDevitt, Miranda Durkie, Norbert Arnold, et al.
The FEBS Journal|June 23, 2015
Detection of novel germline mutations for breast cancer in non-BRCA1/2 familiesFatima Aloraifi, Trudi McDevitt, Rui Martiniano, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 3, 2024
Classification of variants of reduced penetrance in high-penetrance cancer susceptibility genes: Framework for genetics clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group-UK)Alice Garrett, Sophie Allen, Miranda Durkie, et al.
American Journal of Human Genetics|September 9, 2025
Availability of benign missense variant "truthsets" for validation of functional assays: Current status and a systematic approachCharlie F Rowlands, Sophie Allen, Alice Garrett, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
European Journal of Human Genetics : EJHG|December 4, 2008
When good CF tests go badTrudi McDevitt, David Barton
Cancer Genetics|August 8, 2015
Protein-truncating variants in moderate-risk breast cancer susceptibility genes: a meta-analysis of high-risk case-control screening studiesFatima Aloraifi, Damian McCartan, Trudi McDevitt, et al.
Cancer Genetics|June 10, 2017
Recurrent large genomic rearrangements in BRCA1 and BRCA2 in an Irish case seriesTerri P McVeigh, Nuala Cody, Cliona Carroll, et al.
Human Mutation|June 20, 2003
Comparison of the CFTR mutation spectrum in three cohorts of patients of Celtic origin from Brittany (France) and IrelandVirginie Scotet, David E Barton, James B G Watson, et al.
Irish Journal of Medical Science|October 19, 2022
Uptake of BRCA1/BRCA2 predictive genetic testing in an Irish population is low: a missed opportunityDavid E O'Reilly, Lucy Dooley, Geoffrey A Watson, et al.
European Journal of Human Genetics : EJHG|August 2, 2024
Correction: EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancerTrudi McDevitt, Miranda Durkie, Norbert Arnold, et al.
European Journal of Human Genetics : EJHG|March 5, 2024
EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancerTrudi McDevitt, Miranda Durkie, Norbert Arnold, et al.
The FEBS Journal|June 23, 2015
Detection of novel germline mutations for breast cancer in non-BRCA1/2 familiesFatima Aloraifi, Trudi McDevitt, Rui Martiniano, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 3, 2024
Classification of variants of reduced penetrance in high-penetrance cancer susceptibility genes: Framework for genetics clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group-UK)Alice Garrett, Sophie Allen, Miranda Durkie, et al.
American Journal of Human Genetics|September 9, 2025
Availability of benign missense variant "truthsets" for validation of functional assays: Current status and a systematic approachCharlie F Rowlands, Sophie Allen, Alice Garrett, et al.
Pageof 2